- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03142347
Remote Endarterectomy vs Remote Endarterectomy + Drug Coated Balloon (DCB) Angioplasty in Patients With the Femoral Artery Occlusive Disease
May 3, 2017 updated by: Meshalkin Research Institute of Pathology of Circulation
Remote Endarterectomy vs Remote Endarterectomy Supplement DCB Balloon Angioplasty in Patients With the Femoral Artery Occlusive Disease (TASCII D)
Comparison effectiveness two methods revascularization of the superficial femoral artery: remote endarterectomy vs. remote endarterectomy supplemented DCB angioplasty in patients with steno-occlusive lesion of the femoro-popliteal segment of TASCII D
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Given that more and more devices appear to deliver cytotoxic drugs into the depth of atherosclerotic plaque, it is interesting to study the effect of these drugs when applied directly after plaque removal.
Study Type
Interventional
Enrollment (Anticipated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Novosibirsk, Russian Federation, 630055
- Recruiting
- Federal State Institution Academician E.N.Meshalkin Novosibirsk State Research Institute Of Circulation Pathology Rusmedtechnology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 75 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with occlusive lesions of C and D type femoral artery and with chronic lower limb ischemia (II-IV degree by Fontaine, 4-6 degree by Rutherford)
- Patients who consented to participate in this study.
Exclusion Criteria:
- Chronic heart failure of III-IV functional class by New York Heart Association (NYHA) classification.
- Decompensated chronic "pulmonary" heart
- Severe hepatic or renal failure (bilirubin> 35 mmol / l, glomerular filtration rate <60 mL / min);
- Polyvalent drug allergy
- Cancer in the terminal stage with a life expectancy less than 6 months;
- Acute ischemic
- Expressed aortic calcification tolerant to remote endarterectomy
- Patient refusal to participate or continue to participate in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Remote endarterectomy
Open endarterectomy of the common, deep, initial of superficial femoral artery was performed.
Delamination factory complex into the lumen of the loop.
After that, the translational and rotational motions loops under fluoroscopic guidance, continuing detachment of plaque in the antegrade direction to the distal end of plaque.
Plastic arteriotomy wounds performed patches of xenopericardium.
Control patency of the arterial lumen is performed intraoperatively by X-ray angiography.
|
Performed open endarterectomy of the common, deep, initial of superficial femoral artery.
Proximal plaque exfoliate as far as possible in the superficial femoral artery.
After that, the translational and rotational motions loops under fluoroscopic guidance, continuing detachment of plaque in the antegrade direction to the distal end of plaque.
Plastic of arteriotomy wounds performed patches of xenopericardium.
Control patency of the arterial vessel is performed intraoperatively by X-ray angiography.
When rendering residual stenosis or intimal dissection, limiting blood flow, complemented by endovascular intervention plasticity.
|
EXPERIMENTAL: Remote endarterectomy + DCB balloon
Open endarterectomy of the common, deep, initial of superficial femoral artery was performed.
Delamination factory complex into the lumen of the loop.
After that, the translational and rotational motions loops under fluoroscopic guidance, continuing detachment of plaque in the antegrade direction to the distal end of plaque.
Plastic arteriotomy wounds performed patches of xenopericardium.
And balloon angioplasty of superficial femoral artery with DCB balloon is perform.
Control patency of the arterial lumen is performed intraoperatively by X-ray angiography.
|
Performed open endarterectomy of the common, deep, initial of superficial femoral artery.
Proximal plaque exfoliate as far as possible in the superficial femoral artery.
After that, the translational and rotational motions loops under fluoroscopic guidance, continuing detachment of plaque in the antegrade direction to the distal end of plaque.
Plastic of arteriotomy wounds performed patches of xenopericardium.
And balloon angioplasty of superficial femoral artery with DCB balloon is perform.
Control patency of the arterial vessel is performed intraoperatively by X-ray angiography.
When rendering residual stenosis or intimal dissection, limiting blood flow, complemented by endovascular intervention plasticity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the change of lumen in target vessel
Time Frame: Baseline, 3 days after the operation, 6 month, 12 month, 2 years
|
stenosis or occlusions
|
Baseline, 3 days after the operation, 6 month, 12 month, 2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Vessel wall thickness
Time Frame: 3 days after the operation, 6 month, 12 month, 2 years
|
mm
|
3 days after the operation, 6 month, 12 month, 2 years
|
Number of participants with limb salvage
Time Frame: 3 days after the operation, 6 month, 12 month, 2 years
|
3 days after the operation, 6 month, 12 month, 2 years
|
|
Number of participants with complications in long-term period after the operation.
Time Frame: 3 days after the operation, 6 month, 12 month, 2 years
|
3 days after the operation, 6 month, 12 month, 2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 1, 2017
Primary Completion (ANTICIPATED)
January 1, 2018
Study Completion (ANTICIPATED)
January 1, 2019
Study Registration Dates
First Submitted
May 3, 2017
First Submitted That Met QC Criteria
May 3, 2017
First Posted (ACTUAL)
May 5, 2017
Study Record Updates
Last Update Posted (ACTUAL)
May 5, 2017
Last Update Submitted That Met QC Criteria
May 3, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- N-RICP-469
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Femoral Artery Occlusion
-
C. R. BardCompletedRestenosis | Femoral Artery Occlusion | Femoral Artery StenosisUnited States
-
Lifetech Scientific (Shenzhen) Co., Ltd.UnknownPopliteal Artery Occlusion | Iliac Artery Occlusion | Femoral Artery Occlusion | Iliac Artery Stenosis | Femoral Artery Stenosis | Popliteal Arterial StenosisChina
-
Chansu Vascular TechnologiesActive, not recruitingPopliteal Artery Stenosis | Popliteal Artery Occlusion | Femoral Artery Occlusion | Femoral Artery StenosisGermany, France
-
C. R. BardCompletedPopliteal Artery Stenosis | Popliteal Artery Occlusion | Femoral Artery Occlusion | Femoral Artery StenosisUnited States, Germany, Belgium, Austria
-
C. R. BardTerminatedPopliteal Artery Stenosis | Popliteal Artery Occlusion | Femoral Artery Occlusion | Femoral Artery StenosisUnited States
-
Medtronic EndovascularCompletedPopliteal Artery Stenosis | Popliteal Artery Occlusion | Femoral Artery Occlusion | Femoral Artery StenosisUnited States
-
Medtronic EndovascularCompletedPopliteal Artery Stenosis | Popliteal Artery Occlusion | Femoral Artery Occlusion | Femoral Artery StenosisJapan
-
Lifetech Scientific (Shenzhen) Co., Ltd.RecruitingPopliteal Artery Occlusion | Femoral Artery Occlusion | Femoral Artery Stenosis | Popliteal Arterial StenosisChina
-
C. R. BardCompletedFemoral Artery Occlusion | Femoral Arterial StenosisBelgium, Austria, France, Germany, Switzerland
-
University of HelsinkiW.L.Gore & AssociatesTerminatedFemoral Artery OcclusionFinland
Clinical Trials on Remote endarterectomy
-
St. Antonius HospitalUMC Utrecht; Albert Schweitzer Hospital; Amphia HospitalUnknownAtherosclerosis | Peripheral Arterial Occlusive DiseaseNetherlands
-
Perouse MedicalEclevar MedtechCompletedStroke | Artery Stenosis | Artery Stenosis, Carotid | Occlusion of ArteryFrance
-
University Hospital OstravaRecruitingIn-Stent Carotid Artery RestenosisCzechia
-
Xuanwu Hospital, BeijingUnknownStroke | Carotid Stenosis | SurgeryChina
-
CAMC Health SystemCompletedStenoses, Carotid ArteryUnited States
-
Marmara UniversityNot yet recruitingSleep-Disordered Breathing | Chronic Thromboembolic Pulmonary Hypertension | Post OperativeTurkey
-
IRCCS Policlinico S. DonatoUniversity of Pavia; Ministry of Health, ItalyCompleted
-
Ziv HospitalUnknownCarotid Artery StenosisIsrael
-
University of California, San DiegoWithdrawnStroke | Carotid StenosisUnited States
-
Columbia UniversityTerminatedDiabetes | Cognitive Dysfunction | Carotid Artery Stenosis | Carotid Artery DiseaseUnited States